NovaBay Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
/ 
Frequently asked questions
To buy NovaBay Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for NovaBay Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for NovaBay Pharmaceuticals Inc. is NBY:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
NovaBay Pharmaceuticals Inc. has its primary listing on NYSE American. You can trade NovaBay Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, NovaBay Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include NovaBay Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like NovaBay Pharmaceuticals Inc..